NVP-BEP795 and NVP-BEP800: Novel, fragment derived orally bioavailable small molecule Hsp90 inhibitors with potent antitumor activity

被引：0
|
作者：
Massey, Andrew
Brough, Paul
Jensen, Michael
Ruetz, Stephan
Schoepfer, Joseph
Workman, Paul
Garcia-Echeverria, Carlos
Drysdale, Martin
机构：
[1] Vernalis Ltd, Cambridge, England
[2] Novartis Inst Biomed Res, Basel, Switzerland
[3] 3Canc Res UK Ctr Canc Therapeut, Sutton, Surrey, England
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4677
引用
收藏
页数：2
相关论文
共 35 条
  • [1] NVP-BEP800: an orally bioavailable small molecule Hsp90 inhibitor with potent in vivo antitumor activity
    Jensen, Michael
    Schoepfer, Joseph
    Massey, Andrew
    Brough, Paul
    Brueggen, Josef
    Schweitzer, Alain
    Pfaar, Ulrike
    Quadt, Corneiia
    Drysdale, Martin
    Chene, Patrick
    Garcia-Echeverria, Carlos
    CANCER RESEARCH, 2009, 69
  • [2] Preclinical anti-myeloma activity of the novel Hsp90 ATPase inhibitor NVP-BEP800
    Stuehmer, Thorsten
    Jensen, Michael
    Quadt, Cornelia
    Garcia-Echeverria, Carlos
    Bargou, Ralf
    CANCER RESEARCH, 2009, 69
  • [3] Preclinical Antitumor Activity of the Orally Available Heat Shock Protein 90 Inhibitor NVP-BEP800
    Massey, Andrew J.
    Schoepfer, Joseph
    Brough, Paul A.
    Brueggen, Josef
    Chene, Patrick
    Drysdale, Martin J.
    Pfaar, Ulrike
    Radimerski, Thomas
    Ruetz, Stephan
    Schweitzer, Alain
    Wood, Mike
    Garcia-Echeverria, Carlos
    Jensen, Michael Rugaard
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (04) : 906 - 919
  • [4] Anti-myeloma activity of the novel 2-aminothienopyrimidine Hsp90 inhibitor NVP-BEP800
    Stuehmer, Thorsten
    Chatterjee, Manik
    Grella, Evelyn
    Seggewiss, Ruth
    Langer, Christian
    Mueller, Sabine
    Schoepfer, Joseph
    Garcia-Echeverria, Carlos
    Quadt, Cornelia
    Jensen, Michael R.
    Einsele, Hermann
    Bargou, Ralf C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 147 (03) : 319 - 327
  • [5] Novel HSP90 inhibitors, NVP-AUY922 and NVP-BEP800, radiosensitize tumor cell lines under acute hypoxia
    Blassl, C.
    Djuzenova, C. S.
    Katzer, A.
    Tripp, C.
    Roloff, K.
    Bernhard, M.
    Flentje, M.
    Jensen, M. R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 : 74 - 74
  • [6] Tumor cell line specific radiation response to Hsp90 inhibitors NVP-AUY922 and NVP-BEP800 added during and after irradiation
    Hartmann, S.
    Flentje, M.
    Djuzenova, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 : 86 - 86
  • [7] The Hsp90 inhibitors NVP-AUY922 and NVP-BEP800 reduced migration and invasion of irradiated tumor cells cultured under normoxic and hypoxic conditions
    Hartmann, S.
    Guenther, N.
    Biehl, M.
    Flentje, M.
    Djuzenova, C. S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 130 - 130
  • [8] NVP-BEP800/VER-82576: A potent orally active Hsp90 chaperone inhibitor evolved by SBDD from Vernalis fragment ("SeeDs") hits and in silico screening hits
    Davies, Nicholas G. M.
    Barril, X.
    Drysdale, M. J.
    Brough, P. A.
    Eccles, S. A.
    Dymock, B.
    Garcia-Echeverria, Carlos
    Massey, A.
    Radimerski, Thomas
    Raynaud, F. I.
    Jensen, M. Rugaard
    Schoepfer, J.
    Sharp, S. Y.
    Workman, P.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [9] Hsp90 inhibition by NVP-AUY922 and NVP-BEP800 decreases migration and invasion of irradiated normoxic and hypoxic tumor cell lines
    Hartmann, Susanne
    Gunther, Nadine
    Biehl, Marlene
    Katzer, Astrid
    Kuger, Sebastian
    Worschech, Eike
    Sukhorukov, Vladimir L.
    Krohne, Georg
    Zimmermann, Heiko
    Flentje, Michael
    Djuzenova, Cholpon S.
    CANCER LETTERS, 2013, 331 (02) : 200 - 210
  • [10] Hsp90 Inhibitors NVP-AUY922 and NVP-BEP800 May Exert a Significant Radiosensitization on Tumor Cells along with a Cell Type-Specific Cytotoxicity
    Niewidok, Natalia
    Wack, Linda-Jacqueline
    Schiessl, Sarah
    Stingl, Lavinia
    Katzer, Astrid
    Polat, Buelent
    Sukhorukov, Vladimir L.
    Flentje, Michael
    Djuzenova, Cholpon S.
    TRANSLATIONAL ONCOLOGY, 2012, 5 (05): : 356 - U145
1234